Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Research Report 2025(Status and Outlook)
Report Overview
Gastroesophageal Reflux Disease (GERD) drugs and devices refer to pharmaceutical products and medical devices used in the treatment and management of GERD, a chronic condition where stomach acid flows back into the esophagus, causing symptoms such as heartburn and regurgitation. GERD drugs typically include proton pump inhibitors (PPIs), H2 receptor antagonists, and antacids, while GERD devices encompass tools like endoscopes for diagnosis and minimally invasive surgical devices for treatment. These products aim to alleviate symptoms, promote healing of the esophagus, and prevent complications associated with GERD. The market for GERD drugs and devices is driven by the increasing prevalence of GERD globally, lifestyle factors such as obesity and poor diet contributing to the rise in GERD cases, and the growing awareness and diagnosis of the condition among patients and healthcare providers.
Market trends in the GERD drugs and devices market indicate a shift towards minimally invasive procedures and non-pharmacological treatment options, driven by patient preferences for less invasive interventions and the desire to reduce reliance on long-term medication use. Additionally, technological advancements in diagnostic tools and surgical devices are enhancing the precision and effectiveness of GERD treatments, leading to better patient outcomes and reduced recovery times. The market is also witnessing a trend towards personalized medicine, with healthcare providers increasingly tailoring treatment plans to individual patient needs based on factors such as symptom severity, underlying causes, and response to previous therapies. These trends are shaping the landscape of the GERD market, driving innovation and improving the overall quality of care for patients with GERD.
At the same time, market drivers such as the aging population, which is more susceptible to GERD, and the increasing prevalence of risk factors like obesity and poor dietary habits, are fueling the demand for GERD drugs and devices. Rising healthcare expenditure, growing awareness about the importance of early diagnosis and treatment of GERD to prevent complications such as Barrett's esophagus and esophageal cancer, and the expanding access to healthcare services in developing regions are also contributing to market growth. Moreover, strategic collaborations between pharmaceutical companies, medical device manufacturers, and healthcare providers are facilitating the development of innovative products and treatment approaches in the field of GERD management. These market drivers are expected to continue driving growth in the GERD drugs and devices market in the coming years, presenting opportunities for market expansion and technological advancements in the treatment of this chronic condition.
This report provides a deep insight into the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastroesophageal Reflux Disease (GERD) Drugs and Devices market in any manner.
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca
Plc.
Addex Therapeutics
Takeda Pharmaceutical Company Limited
Rottapharm (Meda AB)
Pfizer
Inc.
Eisai Co. Ltd.
The Procter & Gamble Company
Mederi Therapeutics
Aros Pharma
Torax Medical
Inc.
BD
EndoGastric Solutions
Medigus Ltd.
Market Segmentation (by Type)
Medication
Minimally Invasive Surgery
Invasive Surgery
Market Segmentation (by Application)
Heartburn
Acid reflux disorders
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
Gastroesophageal Reflux Disease (GERD) drugs and devices refer to pharmaceutical products and medical devices used in the treatment and management of GERD, a chronic condition where stomach acid flows back into the esophagus, causing symptoms such as heartburn and regurgitation. GERD drugs typically include proton pump inhibitors (PPIs), H2 receptor antagonists, and antacids, while GERD devices encompass tools like endoscopes for diagnosis and minimally invasive surgical devices for treatment. These products aim to alleviate symptoms, promote healing of the esophagus, and prevent complications associated with GERD. The market for GERD drugs and devices is driven by the increasing prevalence of GERD globally, lifestyle factors such as obesity and poor diet contributing to the rise in GERD cases, and the growing awareness and diagnosis of the condition among patients and healthcare providers.
Market trends in the GERD drugs and devices market indicate a shift towards minimally invasive procedures and non-pharmacological treatment options, driven by patient preferences for less invasive interventions and the desire to reduce reliance on long-term medication use. Additionally, technological advancements in diagnostic tools and surgical devices are enhancing the precision and effectiveness of GERD treatments, leading to better patient outcomes and reduced recovery times. The market is also witnessing a trend towards personalized medicine, with healthcare providers increasingly tailoring treatment plans to individual patient needs based on factors such as symptom severity, underlying causes, and response to previous therapies. These trends are shaping the landscape of the GERD market, driving innovation and improving the overall quality of care for patients with GERD.
At the same time, market drivers such as the aging population, which is more susceptible to GERD, and the increasing prevalence of risk factors like obesity and poor dietary habits, are fueling the demand for GERD drugs and devices. Rising healthcare expenditure, growing awareness about the importance of early diagnosis and treatment of GERD to prevent complications such as Barrett's esophagus and esophageal cancer, and the expanding access to healthcare services in developing regions are also contributing to market growth. Moreover, strategic collaborations between pharmaceutical companies, medical device manufacturers, and healthcare providers are facilitating the development of innovative products and treatment approaches in the field of GERD management. These market drivers are expected to continue driving growth in the GERD drugs and devices market in the coming years, presenting opportunities for market expansion and technological advancements in the treatment of this chronic condition.
This report provides a deep insight into the global Gastroesophageal Reflux Disease (GERD) Drugs and Devices market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, value chain analysis, etc.
The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.
In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Gastroesophageal Reflux Disease (GERD) Drugs and Devices market in any manner.
Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Company
AstraZeneca
Plc.
Addex Therapeutics
Takeda Pharmaceutical Company Limited
Rottapharm (Meda AB)
Pfizer
Inc.
Eisai Co. Ltd.
The Procter & Gamble Company
Mederi Therapeutics
Aros Pharma
Torax Medical
Inc.
BD
EndoGastric Solutions
Medigus Ltd.
Market Segmentation (by Type)
Medication
Minimally Invasive Surgery
Invasive Surgery
Market Segmentation (by Application)
Heartburn
Acid reflux disorders
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market
- Overview of the regional outlook of the Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value (USD Billion) data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.
Chapter 12 is the main points and conclusions of the report.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
1.2 Key Market Segments
1.2.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Segment by Type
1.2.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Life Cycle
3.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Manufacturers (2020-2025)
3.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Manufacturers (2020-2025)
3.5 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Sites, Area Served, Product Type
3.8 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Competitive Situation and Trends
3.8.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 PEST Analysis
5.6.1 Industry Policies Analysis
5.6.2 Economic Environment Analysis
5.6.3 Social Environment Analysis
5.6.4 Technological Environment Analysis
5.7 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Porter's Five Forces Analysis
5.7.1 Global Trade Frictions
5.7.2 Global Trade Frictions and Their Impacts to Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market
5.8 ESG Ratings of Leading Companies
6 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Type (2020-2025)
6.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Type (2020-2025)
6.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Price by Type (2020-2025)
7 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Sales by Application (2020-2025)
7.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) by Application (2020-2025)
7.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Growth Rate by Application (2020-2025)
8 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET SALES BY REGION
8.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.1.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.1.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region
8.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region
8.2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region
8.2.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Region
8.3 North America
8.3.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country
8.3.2 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country
8.4.2 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.5.2 Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country
8.6.2 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.7.2 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Region(2020-2025)
9.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Region (2020-2025)
9.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production
9.4.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production Growth Rate (2020-2025)
9.4.2 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production
9.5.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production Growth Rate (2020-2025)
9.5.2 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (2020-2025)
9.6.1 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production Growth Rate (2020-2025)
9.6.2 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (2020-2025)
9.7.1 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production Growth Rate (2020-2025)
9.7.2 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AstraZeneca
10.1.1 AstraZeneca Basic Information
10.1.2 AstraZeneca Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.1.3 AstraZeneca Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.1.4 AstraZeneca Business Overview
10.1.5 AstraZeneca SWOT Analysis
10.1.6 AstraZeneca Recent Developments
10.2 Plc.
10.2.1 Plc. Basic Information
10.2.2 Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.2.3 Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.2.4 Plc. Business Overview
10.2.5 Plc. SWOT Analysis
10.2.6 Plc. Recent Developments
10.3 Addex Therapeutics
10.3.1 Addex Therapeutics Basic Information
10.3.2 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.3.3 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.3.4 Addex Therapeutics Business Overview
10.3.5 Addex Therapeutics SWOT Analysis
10.3.6 Addex Therapeutics Recent Developments
10.4 Takeda Pharmaceutical Company Limited
10.4.1 Takeda Pharmaceutical Company Limited Basic Information
10.4.2 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.4.3 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.4.4 Takeda Pharmaceutical Company Limited Business Overview
10.4.5 Takeda Pharmaceutical Company Limited Recent Developments
10.5 Rottapharm (Meda AB)
10.5.1 Rottapharm (Meda AB) Basic Information
10.5.2 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.5.3 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.5.4 Rottapharm (Meda AB) Business Overview
10.5.5 Rottapharm (Meda AB) Recent Developments
10.6 Pfizer
10.6.1 Pfizer Basic Information
10.6.2 Pfizer Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.6.3 Pfizer Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 Inc.
10.7.1 Inc. Basic Information
10.7.2 Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.7.3 Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.7.4 Inc. Business Overview
10.7.5 Inc. Recent Developments
10.8 Eisai Co. Ltd.
10.8.1 Eisai Co. Ltd. Basic Information
10.8.2 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.8.3 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.8.4 Eisai Co. Ltd. Business Overview
10.8.5 Eisai Co. Ltd. Recent Developments
10.9 The Procter and Gamble Company
10.9.1 The Procter and Gamble Company Basic Information
10.9.2 The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.9.3 The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.9.4 The Procter and Gamble Company Business Overview
10.9.5 The Procter and Gamble Company Recent Developments
10.10 Mederi Therapeutics
10.10.1 Mederi Therapeutics Basic Information
10.10.2 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.10.3 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.10.4 Mederi Therapeutics Business Overview
10.10.5 Mederi Therapeutics Recent Developments
10.11 Aros Pharma
10.11.1 Aros Pharma Basic Information
10.11.2 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.11.3 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.11.4 Aros Pharma Business Overview
10.11.5 Aros Pharma Recent Developments
10.12 Torax Medical
10.12.1 Torax Medical Basic Information
10.12.2 Torax Medical Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.12.3 Torax Medical Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.12.4 Torax Medical Business Overview
10.12.5 Torax Medical Recent Developments
10.13 Inc.
10.13.1 Inc. Basic Information
10.13.2 Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.13.3 Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.13.4 Inc. Business Overview
10.13.5 Inc. Recent Developments
10.14 BD
10.14.1 BD Basic Information
10.14.2 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.14.3 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.14.4 BD Business Overview
10.14.5 BD Recent Developments
10.15 EndoGastric Solutions
10.15.1 EndoGastric Solutions Basic Information
10.15.2 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.15.3 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.15.4 EndoGastric Solutions Business Overview
10.15.5 EndoGastric Solutions Recent Developments
10.16 Medigus Ltd.
10.16.1 Medigus Ltd. Basic Information
10.16.2 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.16.3 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.16.4 Medigus Ltd. Business Overview
10.16.5 Medigus Ltd. Recent Developments
11 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET FORECAST BY REGION
11.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast
11.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country
11.2.3 Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Region
11.2.4 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2026-2033)
12.1.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2026-2033)
12.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Application (2026-2033)
12.2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) Forecast by Application
12.2.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
1.2 Key Market Segments
1.2.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Segment by Type
1.2.2 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Life Cycle
3.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Manufacturers (2020-2025)
3.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Manufacturers (2020-2025)
3.5 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Average Price by Manufacturers (2020-2025)
3.7 Manufacturers Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Sites, Area Served, Product Type
3.8 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Competitive Situation and Trends
3.8.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Concentration Rate
3.8.2 Global 5 and 10 Largest Gastroesophageal Reflux Disease (GERD) Drugs and Devices Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES INDUSTRY CHAIN ANALYSIS
4.1 Gastroesophageal Reflux Disease (GERD) Drugs and Devices Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 PEST Analysis
5.6.1 Industry Policies Analysis
5.6.2 Economic Environment Analysis
5.6.3 Social Environment Analysis
5.6.4 Technological Environment Analysis
5.7 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Porter's Five Forces Analysis
5.7.1 Global Trade Frictions
5.7.2 Global Trade Frictions and Their Impacts to Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market
5.8 ESG Ratings of Leading Companies
6 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Type (2020-2025)
6.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Type (2020-2025)
6.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Price by Type (2020-2025)
7 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Sales by Application (2020-2025)
7.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) by Application (2020-2025)
7.4 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Growth Rate by Application (2020-2025)
8 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET SALES BY REGION
8.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.1.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.1.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region
8.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region
8.2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region
8.2.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Region
8.3 North America
8.3.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country
8.3.2 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country
8.4.2 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.5.2 Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country
8.6.2 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region
8.7.2 Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET PRODUCTION BY REGION
9.1 Global Production of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Region(2020-2025)
9.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Region (2020-2025)
9.3 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production
9.4.1 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production Growth Rate (2020-2025)
9.4.2 North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production
9.5.1 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production Growth Rate (2020-2025)
9.5.2 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (2020-2025)
9.6.1 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production Growth Rate (2020-2025)
9.6.2 Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (2020-2025)
9.7.1 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production Growth Rate (2020-2025)
9.7.2 China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 AstraZeneca
10.1.1 AstraZeneca Basic Information
10.1.2 AstraZeneca Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.1.3 AstraZeneca Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.1.4 AstraZeneca Business Overview
10.1.5 AstraZeneca SWOT Analysis
10.1.6 AstraZeneca Recent Developments
10.2 Plc.
10.2.1 Plc. Basic Information
10.2.2 Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.2.3 Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.2.4 Plc. Business Overview
10.2.5 Plc. SWOT Analysis
10.2.6 Plc. Recent Developments
10.3 Addex Therapeutics
10.3.1 Addex Therapeutics Basic Information
10.3.2 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.3.3 Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.3.4 Addex Therapeutics Business Overview
10.3.5 Addex Therapeutics SWOT Analysis
10.3.6 Addex Therapeutics Recent Developments
10.4 Takeda Pharmaceutical Company Limited
10.4.1 Takeda Pharmaceutical Company Limited Basic Information
10.4.2 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.4.3 Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.4.4 Takeda Pharmaceutical Company Limited Business Overview
10.4.5 Takeda Pharmaceutical Company Limited Recent Developments
10.5 Rottapharm (Meda AB)
10.5.1 Rottapharm (Meda AB) Basic Information
10.5.2 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.5.3 Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.5.4 Rottapharm (Meda AB) Business Overview
10.5.5 Rottapharm (Meda AB) Recent Developments
10.6 Pfizer
10.6.1 Pfizer Basic Information
10.6.2 Pfizer Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.6.3 Pfizer Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.6.4 Pfizer Business Overview
10.6.5 Pfizer Recent Developments
10.7 Inc.
10.7.1 Inc. Basic Information
10.7.2 Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.7.3 Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.7.4 Inc. Business Overview
10.7.5 Inc. Recent Developments
10.8 Eisai Co. Ltd.
10.8.1 Eisai Co. Ltd. Basic Information
10.8.2 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.8.3 Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.8.4 Eisai Co. Ltd. Business Overview
10.8.5 Eisai Co. Ltd. Recent Developments
10.9 The Procter and Gamble Company
10.9.1 The Procter and Gamble Company Basic Information
10.9.2 The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.9.3 The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.9.4 The Procter and Gamble Company Business Overview
10.9.5 The Procter and Gamble Company Recent Developments
10.10 Mederi Therapeutics
10.10.1 Mederi Therapeutics Basic Information
10.10.2 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.10.3 Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.10.4 Mederi Therapeutics Business Overview
10.10.5 Mederi Therapeutics Recent Developments
10.11 Aros Pharma
10.11.1 Aros Pharma Basic Information
10.11.2 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.11.3 Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.11.4 Aros Pharma Business Overview
10.11.5 Aros Pharma Recent Developments
10.12 Torax Medical
10.12.1 Torax Medical Basic Information
10.12.2 Torax Medical Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.12.3 Torax Medical Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.12.4 Torax Medical Business Overview
10.12.5 Torax Medical Recent Developments
10.13 Inc.
10.13.1 Inc. Basic Information
10.13.2 Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.13.3 Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.13.4 Inc. Business Overview
10.13.5 Inc. Recent Developments
10.14 BD
10.14.1 BD Basic Information
10.14.2 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.14.3 BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.14.4 BD Business Overview
10.14.5 BD Recent Developments
10.15 EndoGastric Solutions
10.15.1 EndoGastric Solutions Basic Information
10.15.2 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.15.3 EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.15.4 EndoGastric Solutions Business Overview
10.15.5 EndoGastric Solutions Recent Developments
10.16 Medigus Ltd.
10.16.1 Medigus Ltd. Basic Information
10.16.2 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
10.16.3 Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Market Performance
10.16.4 Medigus Ltd. Business Overview
10.16.5 Medigus Ltd. Recent Developments
11 GASTROESOPHAGEAL REFLUX DISEASE (GERD) DRUGS AND DEVICES MARKET FORECAST BY REGION
11.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast
11.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country
11.2.3 Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Region
11.2.4 South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2026-2033)
12.1.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2026-2033)
12.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Forecast by Application (2026-2033)
12.2.1 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) Forecast by Application
12.2.2 Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Comparison by Region (M USD)
Table 5. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices as of 2024)
Table 10. Global Market Gastroesophageal Reflux Disease (GERD) Drugs and Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Sites and Area Served
Table 12. Manufacturers Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Type
Table 13. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Type (K Units)
Table 25. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (M USD)
Table 26. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) by Type (2020-2025)
Table 27. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Type (2020-2025)
Table 28. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) by Type (2020-2025)
Table 29. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Share by Type (2020-2025)
Table 30. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Price (USD/Unit) by Type (2020-2025)
Table 31. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) by Application
Table 32. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application
Table 33. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Application (2020-2025) & (K Units)
Table 34. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Application (2020-2025)
Table 35. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2020-2025) & (M USD)
Table 36. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application (2020-2025)
Table 37. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Growth Rate by Application (2020-2025)
Table 38. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region (2020-2025) & (K Units)
Table 39. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region (2020-2025)
Table 40. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 41. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Region (2020-2025)
Table 42. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 43. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 45. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 48. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 49. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 52. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units) by Region(2020-2025)
Table 53. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Region (2020-2025)
Table 55. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. AstraZeneca Basic Information
Table 61. AstraZeneca Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 62. AstraZeneca Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca SWOT Analysis
Table 65. AstraZeneca Recent Developments
Table 66. Plc. Basic Information
Table 67. Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 68. Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Plc. Business Overview
Table 70. Plc. SWOT Analysis
Table 71. Plc. Recent Developments
Table 72. Addex Therapeutics Basic Information
Table 73. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 74. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Addex Therapeutics Business Overview
Table 76. Addex Therapeutics SWOT Analysis
Table 77. Addex Therapeutics Recent Developments
Table 78. Takeda Pharmaceutical Company Limited Basic Information
Table 79. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 80. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Takeda Pharmaceutical Company Limited Business Overview
Table 82. Takeda Pharmaceutical Company Limited Recent Developments
Table 83. Rottapharm (Meda AB) Basic Information
Table 84. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 85. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Rottapharm (Meda AB) Business Overview
Table 87. Rottapharm (Meda AB) Recent Developments
Table 88. Pfizer Basic Information
Table 89. Pfizer Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 90. Pfizer Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Pfizer Business Overview
Table 92. Pfizer Recent Developments
Table 93. Inc. Basic Information
Table 94. Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 95. Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Inc. Business Overview
Table 97. Inc. Recent Developments
Table 98. Eisai Co. Ltd. Basic Information
Table 99. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 100. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Eisai Co. Ltd. Business Overview
Table 102. Eisai Co. Ltd. Recent Developments
Table 103. The Procter and Gamble Company Basic Information
Table 104. The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 105. The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. The Procter and Gamble Company Business Overview
Table 107. The Procter and Gamble Company Recent Developments
Table 108. Mederi Therapeutics Basic Information
Table 109. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 110. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Mederi Therapeutics Business Overview
Table 112. Mederi Therapeutics Recent Developments
Table 113. Aros Pharma Basic Information
Table 114. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 115. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Aros Pharma Business Overview
Table 117. Aros Pharma Recent Developments
Table 118. Torax Medical Basic Information
Table 119. Torax Medical Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 120. Torax Medical Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Torax Medical Business Overview
Table 122. Torax Medical Recent Developments
Table 123. Inc. Basic Information
Table 124. Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 125. Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Inc. Business Overview
Table 127. Inc. Recent Developments
Table 128. BD Basic Information
Table 129. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 130. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. BD Business Overview
Table 132. BD Recent Developments
Table 133. EndoGastric Solutions Basic Information
Table 134. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 135. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. EndoGastric Solutions Business Overview
Table 137. EndoGastric Solutions Recent Developments
Table 138. Medigus Ltd. Basic Information
Table 139. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 140. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Medigus Ltd. Business Overview
Table 142. Medigus Ltd. Recent Developments
Table 143. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Region (2026-2033) & (K Units)
Table 144. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Region (2026-2033) & (M USD)
Table 145. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Country (2026-2033) & (K Units)
Table 146. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 147. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Country (2026-2033) & (K Units)
Table 148. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Region (2026-2033) & (K Units)
Table 150. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Region (2026-2033) & (M USD)
Table 151. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Country (2026-2033) & (K Units)
Table 152. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Country (2026-2033) & (Units)
Table 154. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 155. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Type (2026-2033) & (K Units)
Table 156. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Type (2026-2033) & (M USD)
Table 157. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Price Forecast by Type (2026-2033) & (USD/Unit)
Table 158. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) Forecast by Application (2026-2033)
Table 159. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Comparison by Region (M USD)
Table 5. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) by Manufacturers (2020-2025)
Table 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Gastroesophageal Reflux Disease (GERD) Drugs and Devices as of 2024)
Table 10. Global Market Gastroesophageal Reflux Disease (GERD) Drugs and Devices Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 11. Manufacturers Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Sites and Area Served
Table 12. Manufacturers Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Type
Table 13. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Type (K Units)
Table 25. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Type (M USD)
Table 26. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) by Type (2020-2025)
Table 27. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Type (2020-2025)
Table 28. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) by Type (2020-2025)
Table 29. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Share by Type (2020-2025)
Table 30. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Price (USD/Unit) by Type (2020-2025)
Table 31. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) by Application
Table 32. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application
Table 33. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Application (2020-2025) & (K Units)
Table 34. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Application (2020-2025)
Table 35. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Application (2020-2025) & (M USD)
Table 36. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application (2020-2025)
Table 37. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Growth Rate by Application (2020-2025)
Table 38. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region (2020-2025) & (K Units)
Table 39. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region (2020-2025)
Table 40. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 41. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Region (2020-2025)
Table 42. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 43. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 44. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 45. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 46. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region (2020-2025) & (K Units)
Table 47. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 48. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Country (2020-2025) & (K Units)
Table 49. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (2020-2025) & (M USD)
Table 50. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales by Region (2020-2025) & (K Units)
Table 51. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Region (2020-2025) & (M USD)
Table 52. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units) by Region(2020-2025)
Table 53. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue (US$ Million) by Region (2020-2025)
Table 54. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Market Share by Region (2020-2025)
Table 55. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 56. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 57. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 58. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 59. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 60. AstraZeneca Basic Information
Table 61. AstraZeneca Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 62. AstraZeneca Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 63. AstraZeneca Business Overview
Table 64. AstraZeneca SWOT Analysis
Table 65. AstraZeneca Recent Developments
Table 66. Plc. Basic Information
Table 67. Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 68. Plc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 69. Plc. Business Overview
Table 70. Plc. SWOT Analysis
Table 71. Plc. Recent Developments
Table 72. Addex Therapeutics Basic Information
Table 73. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 74. Addex Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 75. Addex Therapeutics Business Overview
Table 76. Addex Therapeutics SWOT Analysis
Table 77. Addex Therapeutics Recent Developments
Table 78. Takeda Pharmaceutical Company Limited Basic Information
Table 79. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 80. Takeda Pharmaceutical Company Limited Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 81. Takeda Pharmaceutical Company Limited Business Overview
Table 82. Takeda Pharmaceutical Company Limited Recent Developments
Table 83. Rottapharm (Meda AB) Basic Information
Table 84. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 85. Rottapharm (Meda AB) Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 86. Rottapharm (Meda AB) Business Overview
Table 87. Rottapharm (Meda AB) Recent Developments
Table 88. Pfizer Basic Information
Table 89. Pfizer Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 90. Pfizer Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 91. Pfizer Business Overview
Table 92. Pfizer Recent Developments
Table 93. Inc. Basic Information
Table 94. Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 95. Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 96. Inc. Business Overview
Table 97. Inc. Recent Developments
Table 98. Eisai Co. Ltd. Basic Information
Table 99. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 100. Eisai Co. Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 101. Eisai Co. Ltd. Business Overview
Table 102. Eisai Co. Ltd. Recent Developments
Table 103. The Procter and Gamble Company Basic Information
Table 104. The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 105. The Procter and Gamble Company Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 106. The Procter and Gamble Company Business Overview
Table 107. The Procter and Gamble Company Recent Developments
Table 108. Mederi Therapeutics Basic Information
Table 109. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 110. Mederi Therapeutics Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 111. Mederi Therapeutics Business Overview
Table 112. Mederi Therapeutics Recent Developments
Table 113. Aros Pharma Basic Information
Table 114. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 115. Aros Pharma Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 116. Aros Pharma Business Overview
Table 117. Aros Pharma Recent Developments
Table 118. Torax Medical Basic Information
Table 119. Torax Medical Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 120. Torax Medical Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 121. Torax Medical Business Overview
Table 122. Torax Medical Recent Developments
Table 123. Inc. Basic Information
Table 124. Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 125. Inc. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 126. Inc. Business Overview
Table 127. Inc. Recent Developments
Table 128. BD Basic Information
Table 129. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 130. BD Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 131. BD Business Overview
Table 132. BD Recent Developments
Table 133. EndoGastric Solutions Basic Information
Table 134. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 135. EndoGastric Solutions Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 136. EndoGastric Solutions Business Overview
Table 137. EndoGastric Solutions Recent Developments
Table 138. Medigus Ltd. Basic Information
Table 139. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Overview
Table 140. Medigus Ltd. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units), Revenue (M USD), Price (USD/Unit) and Gross Margin (2020-2025)
Table 141. Medigus Ltd. Business Overview
Table 142. Medigus Ltd. Recent Developments
Table 143. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Region (2026-2033) & (K Units)
Table 144. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Region (2026-2033) & (M USD)
Table 145. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Country (2026-2033) & (K Units)
Table 146. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 147. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Country (2026-2033) & (K Units)
Table 148. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 149. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Region (2026-2033) & (K Units)
Table 150. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Region (2026-2033) & (M USD)
Table 151. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Country (2026-2033) & (K Units)
Table 152. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 153. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Country (2026-2033) & (Units)
Table 154. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Country (2026-2033) & (M USD)
Table 155. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Type (2026-2033) & (K Units)
Table 156. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Type (2026-2033) & (M USD)
Table 157. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Price Forecast by Type (2026-2033) & (USD/Unit)
Table 158. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) Forecast by Application (2026-2033)
Table 159. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD), 2024-2033
Figure 5. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) (2020-2033)
Figure 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Life Cycle
Figure 13. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Share by Manufacturers in 2024
Figure 14. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Manufacturers in 2024
Figure 15. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Gastroesophageal Reflux Disease (GERD) Drugs and Devices Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in 2024
Figure 18. Industry Chain Map of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
Figure 19. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market PESTE Analysis
Figure 20. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Type
Figure 27. Sales Market Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2020-2025)
Figure 28. Sales Market Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type in 2024
Figure 29. Market Size Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2020-2025)
Figure 30. Market Size Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application
Figure 33. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Application (2020-2025)
Figure 34. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Application in 2024
Figure 35. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application (2020-2025)
Figure 36. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application in 2024
Figure 37. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region (2020-2025)
Figure 39. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Region (2020-2025)
Figure 40. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Country in 2024
Figure 43. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Country in 2024
Figure 45. U.S. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Country in 2024
Figure 53. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Country in 2024
Figure 55. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Region in 2024
Figure 68. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (K Units)
Figure 79. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Country in 2024
Figure 80. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (M USD)
Figure 81. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Country in 2024
Figure 82. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production Market Share by Region (2020-2025)
Figure 103. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Forecast by Type (2026-2033)
Figure 111. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Application (2026-2033)
Figure 112. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD), 2024-2033
Figure 5. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) (2020-2033)
Figure 6. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Product Life Cycle
Figure 13. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Share by Manufacturers in 2024
Figure 14. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue Share by Manufacturers in 2024
Figure 15. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Gastroesophageal Reflux Disease (GERD) Drugs and Devices Average Price (USD/Unit) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Gastroesophageal Reflux Disease (GERD) Drugs and Devices Revenue in 2024
Figure 18. Industry Chain Map of Gastroesophageal Reflux Disease (GERD) Drugs and Devices
Figure 19. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market PESTE Analysis
Figure 20. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Type
Figure 27. Sales Market Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2020-2025)
Figure 28. Sales Market Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type in 2024
Figure 29. Market Size Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type (2020-2025)
Figure 30. Market Size Share of Gastroesophageal Reflux Disease (GERD) Drugs and Devices by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application
Figure 33. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Application (2020-2025)
Figure 34. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Application in 2024
Figure 35. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application (2020-2025)
Figure 36. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share by Application in 2024
Figure 37. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Growth Rate by Application (2020-2025)
Figure 38. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region (2020-2025)
Figure 39. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Region (2020-2025)
Figure 40. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 41. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 42. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Country in 2024
Figure 43. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Country in 2024
Figure 45. U.S. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 46. U.S. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (K Units) and Growth Rate (2020-2025)
Figure 48. Canada Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 52. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Country in 2024
Figure 53. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Country in 2024
Figure 55. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 56. Germany Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 58. France Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 60. U.K. Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 62. Italy Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 64. Spain Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (K Units)
Figure 66. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region in 2024
Figure 67. Asia Pacific Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Region in 2024
Figure 68. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 69. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 71. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 73. South Korea Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 75. India Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 77. Southeast Asia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (K Units)
Figure 79. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Country in 2024
Figure 80. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (M USD)
Figure 81. South America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Country in 2024
Figure 82. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 83. Brazil Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 85. Argentina Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 87. Columbia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (K Units)
Figure 89. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 93. Saudi Arabia Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 95. UAE Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 97. Egypt Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 99. Nigeria Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales and Growth Rate (2020-2025) & (K Units)
Figure 101. South Africa Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production Market Share by Region (2020-2025)
Figure 103. North America Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 104. Europe Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 105. Japan Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 106. China Gastroesophageal Reflux Disease (GERD) Drugs and Devices Production (K Units) Growth Rate (2020-2025)
Figure 107. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Volume (2020-2033) & (K Units)
Figure 108. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Forecast by Type (2026-2033)
Figure 111. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Sales Forecast by Application (2026-2033)
Figure 112. Global Gastroesophageal Reflux Disease (GERD) Drugs and Devices Market Share Forecast by Application (2026-2033)
